Skip to main content
. 2021 Oct 9;269(3):1670–1677. doi: 10.1007/s00415-021-10836-8

Fig. 2.

Fig. 2

Different factors highlighting the need for early initiation of HE DMTs in PLwMS. EDSS Expanded Disability Status Scale, DMT disease-modifying therapy, HE high efficacy, ME moderate efficacy, MS multiple sclerosis, NEDA no evidence of disease activity, PLwMS people living with MS, SPMS secondary progressive MS